Accelerating cervical cancer screening for people living with HIV in low-resource settings
Official title: ACCESS: Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services
Funded at University of California, San Diego · NIH-11535273 · Data updated 2026-11-12
A US and Nigerian collaboration tests two practical ways to get more HIV patients screened and treated for cervical cancer, aiming to scale up in low-income and rural areas.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 7, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $458,179 |
| NIH project number | 3U01CA275118-05S1 |
| Project ID | NIH-11535273 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women living with HIV in settings with limited resources who are eligible for cervical cancer screening and treatment.
✕Less likely to help
Patients in areas without HIV care linkage or where screening/treatment is not feasible may not benefit.
What this research studies
This project uses real-world settings in Nigeria to compare two implementation approaches for offering cervical cancer screening and treatment to women living with HIV. If the strategies work, they could be applied in the United States to improve access for HIV patients in underserved communities. The study builds on a pilot program and focuses on adoption, reach, and long-term sustainability of the screen-and-treat pathway. Researchers will measure how well each approach reaches WLHIV, prompts screening, and maintains services over time.
Why it matters
Potential benefit: If successful, patients could gain faster, more reliable access to cervical cancer screening and treatment integrated with HIV care.
How similar studies have gone: Prior pilots in Nigeria showed feasibility; this project tests scalable strategies to broaden impact.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Aarons, Gregory — University of California, San Diego
- Study coordinator: Aarons, Gregory
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.